Manufacturing Operations
The growth of the company and our industry-leading position in our core business lines, requires tight coordination of our global manufacturing footprint.
Harmonization and expanding our base
From our 10 manufacturing and distribution facilities around the world, our 2,000 employees are dedicated to the planning, purchasing, manufacturing and distribution of our products globally.
One action we took in 2024 was to expand and grow our capabilities in specialized diagnostics by acquiring outright our Transplant Technology Center in Waukesha, WI. We also grew our capacity for innovation at our Hemostasis and Acute Care Diagnostics Technology Center in Bedford, MA, USA. The new building adds 105,000 additional square feet, and represents an investment of more than US$50 million.
Our goal is to harmonize critical processes and systems, implement operational excellence initiatives, drive best practices, and manage our industrial real estate portfolio. And we work closely with the manufacturing heads of our eight Technology Centers and distribution centers.
We achieve exceptional customer experience through manufacturing high-quality instruments and reagents, providing our customers what they need, when they need it.
Mark Olsen
Chief Manufacturing and Supply Chain Officer
Manufacturing and distribution around the world
Hemostasis and Blood Gas Reagents
Patient Blood Management
Whole Blood Hemostasis
Transfusion and Transplant
Autoimmunity
Clinical Chemistry
Immunoassay Technology Center
Logistics Centers
-
Hemostasis and Acute Care:
Hemostasis and Blood Gas Reagents
Patient Blood Management
Whole Blood Hemostasis
-
Transfusion and Transplant:
Transfusion and Transplant
-
Autoimmunity:
Autoimmunity
-
Clinical Chemistry:
Clinical Chemistry
-
Immunoassay:
Immunoassay Technology Center
-
Logistics Centers:
Logistics Centers